Lionco Pharmaceutical Group Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 477.927 million compared to CNY 473.772 million a year ago. Operating income was CNY 76.650 million compared to CNY 86.530 million a year ago. Net income was CNY 68.782 million compared to CNY 76.292 million a year ago. Basic earnings per share from continuing operations was CNY 0.1 compared to CNY 0.11 a year ago.